1/7 Very important descriptive study 👇 expanding our understanding of burden of #CMD + endothelial dysfunction in #INOCA (angina) by @TomJFord@ColinBerryMD @CircIntv
Pts undergoing clinically indicated elective coronary angiography for angina & had definite (typical) or probable (atypical) angina based on Rose angina questionnaire
4/7 Coronary vascular function (reactivity testing) was done (LAD only) in 151 of 185 #INOCA participants (74% 🙎♀️)
Abnl test 89%:
CMD only 51%
Endothelial dysfxn only 17%
Both 21%
Normal test 11% (non-cardiac CP)
5/7 Quality of Life Differences between MVA & VSA:
VSA group had almost 20% lower overall angina summary score (SAQ) compared with MVA
6/7 Take Home Message:
>1/3 of pts with symptom/signs of INOCA have identifiable disorders of coronary vasomotion including MVA and/or VSA
Traditional CV scores do not predict risk of these disorders
Pts with #INOCA have similar angina burden but worse QoL than obstructive CAD
7/7 There is significant overlap between epicardial & microvascular dysfunction. We know this from at least 2 previous publications👇
However, this @CircIntv study is the first study covering all phenotypes of epicardial & microvascular dysfunction in setting of #INOCA
@ColinBerryMD@Michel_CorbanMD@ahmedalbadrimd#CircIntvJC
I believe prevalence of epi endo dysfn in this study may be underestimated because you used a very strict definition of >20% constriction to define it. While debatable, some use <0% constriction or even <20% vasodilation
• • •
Missing some Tweet in this thread? You can try to
force a refresh
#CMD shares similar RFs w epicardial atherosclerosis (traditional ASCVD RFs) & is associated with several biomarkers of inflammation, oxidative stress & coagulation
In our IVUS study:
✅ Most patients with #CMD had significant plaque burden
✅ Patients with #CMD had higher plaque burden & more diffuse atherosclerosis as compared to patients w/o CMD
✅ Angina ➡ poor prognosis
✅ Angina with no obstructive CAD = ⬆ risks of CV events compared to no angina, even after adjusting for traditional RFs & co-morbidities
✅ What Is #CMD & Why Is It Important?
✅ Dx & Risk Stratification of #CMD: Stress Testing & Noninvasive Imaging
✅ Catheter-Based Techniques in Dx of #CMD
✅ Emerging Link Between #CMD & #HFpEF
✅ Phenotype-Based Mngmt of #CMD
🔘 Strengths/Limits of Lesion Specific vs Myocardial Ischemia
🔘 Comparing Dx Accuracy of Tests
🔘 Ischemia Testing in #INOCA
🔘 How to Select Best Noninvasive Test
☢ Issues with proposed #FFR threshold 0.8
☢ Exercise MPI correlates well with FFR but not at 0.8
☢ Benefit of FFR-guided revasc dominantly occurs w/ thresholds <0.8
☢ Quantification of lesion-specific #ischemia insufficient for patient mgmt